Sabril: Clinical Trials

9 trials of Sabril, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 terminated, 1 recruiting, 1 withdrawn. 4 Phase 2, 2 Phase 3, 2 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Terminated 1
Phase 32Terminated 1, Withdrawn 1
Phase 42Completed 1, Terminated 1
Not applicable1Recruiting 1

Follow Sabril: new trials by email Literature Review of Sabril trials Research Report on Sabril

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vigabatrin and Insulin Sensitivity
Vigabatrin - NAFLD, Obesity
Phase 2CompletedWashington University School of Medicine42021-08-232025-01-14
Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm
Combination therapy with vigabatrin and prednisolone, Vigabatrin Tablets - Infantile Spasm, West Syndrome
Not applicableRecruitingKullasate Sakpichaisakul2502020-05-182021-08-25
A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms
Cannabidiol Oral Solution, Placebo, Vigabatrin - Infantile Spasm
Phase 3TerminatedRadius Pharmaceuticals, Inc.22018-09-052023-06-07
Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile Spasms
Prednisolone, Vigabatrin - Infantile Spasms
Phase 3WithdrawnThe Hospital for Sick Children2017-09-052019-11-14
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
Early Vigabatrin, Delayed Vigabatrin (Placebo) - Tuberous Sclerosis Complex
Phase 2CompletedMartina Bebin842016-12-012024-08-19
Vigabatrin for Cocaine and Alcohol Dependence
Vigabatrin, Placebo - Alcoholism, Cocaine Dependence
Phase 2TerminatedUniversity of Pennsylvania322011-04-012019-09-06
A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (SabrilĀ®)
Sabril - Adult Refractory Complex Partial Seizures
Phase 4CompletedLundbeck LLC652010-12-012016-06-07
Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients
vigabatrin - Complex Partial Seizures
Phase 4TerminatedUniversity of Pennsylvania12010-08-012017-07-12
Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence
Vigabatrin, Placebo, Group therapy - Cocaine Dependence
Phase 2CompletedNYU Langone Health1002007-04-012008-04-11

Conditions studied

Spasms, Infantile (3)  ·  Cocaine-Related Disorders (2)  ·  Seizures (2)  ·  Tuberous Sclerosis (2)  ·  Alcoholism (1)  ·  Behavior, Addictive (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Epilepsy (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Obesity (1)

Sponsors

University of Pennsylvania (2)  ·  Kullasate Sakpichaisakul (1)  ·  Lundbeck LLC (1)  ·  Martina Bebin (1)  ·  NYU Langone Health (1)  ·  Radius Pharmaceuticals, Inc. (1)  ·  The Hospital for Sick Children (1)  ·  Washington University School of Medicine (1)

Countries

United States (6)  ·  Canada (1)  ·  Mexico (1)  ·  Thailand (1)

Top investigators

Carter Snead, MD (1)  ·  Emilia Figueroa, M.D. (1)  ·  John Pollard, MD (1)  ·  Jonathan D Brodie, Ph.D., M.D. (1)  ·  Kullasate Sakpichaisakul, MD (1)  ·  Kyle M Kampman, M.D. (1)  ·  Martina Bebin, MD, MPA (1)  ·  Samuel Klein, MD (1)

Results publications

PMID 10368073, PMID 10561962, PMID 10565592, PMID 11673582, PMID 12403260, PMID 14734931, PMID 15159460, PMID 15509243, PMID 15541450, PMID 18077226, PMID 19651710, PMID 20608959, PMID 21070215, PMID 22689735, PMID 22859699, PMID 24657009, PMID 26216500, PMID 26280806, PMID 26302697, PMID 27838190, PMID 29105055, PMID 29966811, PMID 31912454, PMID 37638552, PMID 40116235, PMID 4515986, PMID 6308515, PMID 6539199, PMID 8604274, PMID 8681895

NIH funding

P50DA012756 (1), U01NS092595 (1)